Satellos Bioscience Inc Com V.ICO

Primary Symbol: ICOTF

Healthcare Biotechnology

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...

GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > See “Risk Factors”.

<< Previous

Bullboard Posts

Next >>

Comment by mmayeron Aug 09, 2018 9:40am

46 Views

Post# 28432584

RE:See “Risk Factors”.

You forgot to mention how cosmic rays may erode the sp.
you also forgot the risk if an atomic bomb or an alien invasion!

come on... get with the program!

allain250 wrote:
There is currently no market through which these securities, other than our

Common Shares, may be sold and purchasers may not be able to resell such securities purchased under this short form

prospectus. This may affect the pricing of our securities, other than our Common Shares, in the secondary market, the

transparency and availability of trading prices, the liquidity of these securities and the extent of issuer regulation. See “Risk

Factors”.